Omicron sub-variant BA.2 makes up about 35% of Covid variants in US

As of March 20, the seven-day moving average of US Covid-19 cases was 27,786, down 17.6% from a week earlier.

coronavirus
Photo by Viktor Forgacs on Unsplash
Reuters
2 min read Last Updated : Mar 22 2022 | 8:29 PM IST
The BA.2 sub-variant of Omicron makes up over a third of all coronavirus variants circulating in the United States, according to an estimate from the US Centers for Disease Control and Prevention (CDC) on Tuesday.

Covid-19 infections in the United States have receded sharply since hitting record levels in January, although a coronavirus resurgence in parts of Asia and Europe due to the BA.2 sub-variant has raised some concerns.

As of March 20, the seven-day moving average of US Covid-19 cases was 27,786, down 17.6% from a week earlier.

Most of the United States is considered to have low transmission, under new CDC guidelines introduced last month, which emphasized hospitalization rates and advised most Americans they no longer needed to wear masks.

Other Omicron sub-variants that have been circulating since December’s called BA.1.1 and BA.1.1.529 now make up around 57.3% and 7.9%, respectively, of circulating variants.

The CDC estimates that BA.2 made up 22.3% circulating variants in the country for the week ending March 12, revised down from 23.1%, according to a CDC model that estimates proportions of circulating variants.

The CDC has in the past revised its estimates as it gets more data.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story